IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation

Autor:	Manasson, Julia, Wallach, David S, Guggino, Giuliana, Stapylton, Matthew, Badri, Michelle H, Solomon, Gary, Reddy, Soumya M, Coras, Roxana, Aksenov, Alexander A, Jones, Drew R, Girija, Parvathy V, Neimann, Andrea L, Heguy, Adriana, Segal, Leopoldo N, Dorrestein, Pieter C, Bonneau, Richard, Guma, Monica, Ciccia, Francesco, Ubeda, Carles, Clemente, Jose C, Scher, Jose U
Přispěvatelé:	Manasson, Julia, Wallach, David S, Guggino, Giuliana, Stapylton, Matthew, Badri, Michelle H, Solomon, Gary, Reddy, Soumya M, Coras, Roxana, Aksenov, Alexander A, Jones, Drew R, Girija, Parvathy V, Neimann, Andrea L, Heguy, Adriana, Segal, Leopoldo N, Dorrestein, Pieter C, Bonneau, Richard, Guma, Monica, Ciccia, Francesco, Ubeda, Carle, Clemente, Jose C, Scher, Jose U
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	Settore MED/16 - Reumatologia IL-17 inhibitor Psoriatic arthriti Spondyloarthritis Microbiome Candida
Popis:	To characterize the ecological effects of biologic therapies on the gut bacterial and fungal microbiome of psoriatic arthritis (PsA)/spondyloarthritis (SpA) patients.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a333e319e8ba06af61c6cc8630117bac http://hdl.handle.net/11591/422629 Zobrazit plný text záznamu